← FDA DRUG APPROVALS

FDA ANDA · ANDA087854

THEOBID JR.

Sponsor: WHITBY

APPLICATION
ANDA087854
TYPE
ANDA
ORIGINAL APPROVAL
1985-03-20
LATEST ACTION
1985-03-20
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

THEOBID JR.Discontinued
THEOPHYLLINE 130MG · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

1985-03-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →